Sodium Chloride

Product NDC: 70369-007
11-digit product format: 703690007
Labeler code: 70369
Product ID: 70369-007_2ce83af4-bf51-bf5f-e063-6294a90ae962
Type: HUMAN OTC DRUG
Nonproprietary name: Sodium Chloride
Dosage form: TABLET
Route: ORAL
Labeler: Citragen Pharmaceuticals Inc
Application: M018
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2019-03-22
Substance: SODIUM CHLORIDE
Active strength: 1 g/1
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70369-007-07	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70369-007-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70369-007-03	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70369-007-07	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70369-007-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70369-007-03	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70369-007-07	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70369-007-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70369-007-03	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Sodium Chloride
Brand name suffix: Normal Salt
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
SODIUM CHLORIDE	1 g/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
451W47IQ8X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
313009	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
82c29f1d-a018-7483-e053-2a91aa0a8f7e	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
70369-007-02	2025-02-01	Sodium Chloride Tablets, USP
70369-007-03	2025-02-01	Sodium Chloride Tablets, USP
70369-007-07	2025-02-01	Sodium Chloride Tablets, USP
70369-007-02	2025-01-30	Sodium Chloride Tablets, USP
70369-007-03	2025-01-30	Sodium Chloride Tablets, USP
70369-007-07	2025-01-30	Sodium Chloride Tablets, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
70369-007-02	Sodium ChlorideNormal Salt	500 in 1 BOTTLE	TABLET	500	4
70369-007-03	Sodium ChlorideNormal Salt	100 in 1 BOTTLE	TABLET	100	4
70369-007-07	Sodium ChlorideNormal Salt	300 in 1 BOTTLE	TABLET	300	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70369-007	SODIUM CHLORIDE NORMAL SALT (SODIUM CHLORIDE) TABLET [CITRAGEN PHARMACEUTICALS INC]	4	Current NDC, Legacy NDC, 3 package rows	20250131_82c29f1d-a018-7483-e053-2a91aa0a8f7e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 25 of 25 · 494 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rugby Lubricating Drops	POLYVINYL ALCOHOL	A-S Medication Solutions	f2e26f85-4081-425b-9c81-ac2a079a5743	2023-11-10	Warnings	Exact identifier application number: M018
Saline	NASAL	GERI-CARE PHARMACEUTICAL CORP	d293cc13-4043-0d58-e053-2995a90a3fbc	2023-10-24	Warnings	Exact identifier application number: M018
Eyeganics Organic Tears	GLYCERIN	Eyeganics LLC	42470af7-a3ae-4e14-88e0-04cd92db4b37	2023-10-13	Warnings	Exact identifier application number: M018
Refresh Digital PF	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80	Allergan, Inc.	97e83e68-6374-4df4-93f6-d707fc32748d	2022-11-28	Warnings	Exact identifier application number: M018
Refresh Digital	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80	Allergan, Inc.	b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81	2022-11-28	Warnings	Exact identifier application number: M018
REFRESH OPTIVE	CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN	Allergan, Inc.	7f8d88af-fd3b-4138-af61-f24c59ccebd7	2022-09-23	Warnings	Exact identifier application number: M018
REFRESH OPTIVE Advanced	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80	Allergan, Inc.	ebd0839e-2e1d-4e0e-986c-19f1f5c76358	2022-09-15	Warnings	Exact identifier application number: M018
REFRESH OPTIVE Advanced	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80	Allergan, Inc.	aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0	2022-09-01	Warnings	Exact identifier application number: M018
REFRESH TEARS	CARBOXYMETHYLCELLULOSE SODIUM	Allergan, Inc.	329d1fe0-4432-4565-b7b1-65666bd86526	2022-06-30	Warnings	Exact identifier application number: M018
REFRESH Optive Mega-3	CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80	Allergan, Inc.	c5f2b3f2-2071-45bd-a010-67f848bc0233	2022-06-30	Warnings	Exact identifier application number: M018
REFRESH P.M.	MINERAL OIL, PETROLATUM	Allergan, Inc.	24365d64-cd94-41cc-a7e1-033102d98114	2022-06-30	Warnings	Exact identifier application number: M018
REFRESH PLUS	CARBOXYMETHYLCELLULOSE SODIUM	Allergan, Inc.	0f6a4b4b-cde6-4518-84b5-ce997f1154a7	2022-06-28	Warnings	Exact identifier application number: M018
CIRCLE K sterile eye drops	TETRAHYDROZOLINE HCL	Lil' Drug Store Products, Inc.	2c0e106c-16f6-ff4e-e063-6294a90a7dbb	2018-07-30	Warnings	Exact identifier application number: M018
Lil Drug Store Sterile Eye Drops Redness Reliever	TETRAHYDROZOLINE HCL	Lil' Drug Store Products, Inc.	2c0ea35c-ac52-1043-e063-6394a90a061c	2018-04-30	Warnings	Exact identifier application number: M018

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
451W47IQ8X	SODIUM CHLORIDE	7647-14-5	SODIUM CHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313009	sodium chloride 1 GM Oral Tablet	PSN	82c29f1d-a018-7483-e053-2a91aa0a8f7e	4
313009	sodium chloride 1000 MG Oral Tablet	SCD	82c29f1d-a018-7483-e053-2a91aa0a8f7e	4
313009	NaCl 1000 MG Oral Tablet	SY	82c29f1d-a018-7483-e053-2a91aa0a8f7e	4
313009	sodium chloride 0.124 MEQ/ML Oral Solution	SY	82c29f1d-a018-7483-e053-2a91aa0a8f7e	4
313009	sodium chloride 0.171 MEQ/ML Oral Solution	SY	82c29f1d-a018-7483-e053-2a91aa0a8f7e	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70369-007-02	70369000702	500 TABLET in 1 BOTTLE (70369-007-02)	500 tablet	2019-03-22	0000-00-00	No	No	Current
70369-007-03	70369000703	100 TABLET in 1 BOTTLE (70369-007-03)	100 tablet	2019-03-22	0000-00-00	No	No	Current
70369-007-07	70369000707	300 TABLET in 1 BOTTLE (70369-007-07)	300 tablet	2020-03-09	0000-00-00	No	No	Current